Company Overview and News

1
Have a Drink, Grab a Nickel on Energy Earnings Call ‘Buzzwords’ - Bloomberg

14h bloomberg
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.
Upvote Downvote

 
Is VLO An Acronym For Volatility?

2018-04-17 seekingalpha
With the equity market wobbling, investors have been finding refuge, er, returns in an unlikely quarter - the oil sector. No, not integrated behemoths like Exxon Mobil Corp. (NYSE:XOM), but independent refiners such as Valero Energy Corp. (NYSE:VLO). Over the past 12 months, refiners have outdone the S&P 500 Composite by either a smidgen or a mile. Here's a picture of the bigger refiners' recent performance:
Upvote Downvote

 
Range Resources Could Report Higher Profits in 1Q18

2018-04-16 marketrealist
Range Resources (RRC) is scheduled to report its 1Q18 earnings on April 25, 2018, after the market closes. For 1Q18, excluding any one-time items, the current consensus net income estimate for Range Resources is ~$105 million. On a YoY (year-over-year) basis, Range Resources is expected to report ~72% higher profits compared to the adjusted net income of ~$61 million in 1Q17. On a sequential basis and excluding any one-time items, Range Resources’ 1Q18 consensus net income estimate is ~91% higher than the profit of ~$55 million in 4Q17.
Upvote Downvote

 
Kimberly Warnica Joins Alta Mesa Senior Leadership Team as General Counsel

2018-04-16 globenewswire
HOUSTON, April 16, 2018 (GLOBE NEWSWIRE) -- Alta Mesa Resources, Inc. (NASDAQ:AMR) (“Alta Mesa” or the “Company”) today announced that Kimberly Warnica has joined the Company as Vice President, General Counsel, Chief Compliance Officer, and Corporate Secretary, reporting to President and Chief Executive Officer, Hal Chappelle.
Upvote Downvote

 
Broadcom, Marathon Oil rise; Wells Fargo, Zillow fall

2018-04-13 nzherald.co.nz
The bank said its results may have to be revised following an offer by regulators to settle investigations at a cost of $1 billion.
Upvote Downvote

2
1
 
Should You Invest in the Guggenheim S&P 500 Equal Weight Energy ETF (RYE)?

2018-04-13 zacks
If you're interested in broad exposure to the Energy - Broad segment of the U.S. equity market, look no further than the Guggenheim S&P 500 Equal Weight Energy ETF (RYE - Free Report) , a passively managed exchange traded fund launched on 11/01/2006.
Upvote Downvote

 
Why the Run in Marathon Oil Corporation Stock Will Continue

2018-04-10 investorplace
Traders are buying the crude oil dip with aggression this morning. The surge should bring renewed optimism to the space and it provides a good reason for re-assessing the energy sector for trade ideas. Marathon Oil Corporation (NYSE:MRO) has been on my radar for the past month, and it’s time we give MRO stock its due.
Upvote Downvote

 
Stocks jump as China's president eases trade fight fears

2018-04-10 nzherald.co.nz
NEW YORK (AP) — Stocks are rising on Wall Street Tuesday after Chinese President Xi Jinping offered possible concessions in a trade dispute with the U.S. Xi promised to reduce China's tariffs on imported cars and to improve intellectual property protection, steps that could help the U.S. and China reduce recent tensions over trade. The Dow Jones industrial average rose as much as 400 points in early trading.
Upvote Downvote

 
Where ConocoPhillips Stock Could Settle this Week

2018-04-09 marketrealist
As of April 6, ConocoPhillips (COP) had an implied volatility of ~28.3%, which is higher than its implied volatility of ~21.0% on December 29, 2017. Last week, COP’s implied volatility had increased from ~26.5% to ~28.3% due to strong daily up- and down-moves in its stock price.
Upvote Downvote

 
How Hedge Funds View ConocoPhillips Stock

2018-04-09 marketrealist
In 4Q17, 51 hedge funds bought ConocoPhillips’s (COP) stock and 61 hedge funds sold the stock. The total selling hedge funds outnumbered the total buying hedge funds by ten. As of December 31, 2017, 109 hedge funds that filed form 13Fs held COP in their portfolios. Four counted COP among their top ten holdings.
Upvote Downvote

 
A Different Way Of Measuring Performance

2018-04-09 seekingalpha
Simply looking at portfolio performance gives you little information about what is working for you and what is not.
Upvote Downvote

 
7 Stocks to Buy That Are Leading the Way Higher

2018-04-05 investorplace
Stocks are rebounding strongly on Thursday ahead of Friday’s big non-farm payrolls report thanks to easing fears over U.S.-China trade tensions. Investors are realizing that opening tariff salvos are unlikely to be implemented. Instead, they are an opening gambit in what’s set to be a long and high-stakes negotiation.
Upvote Downvote

 
MRO / Marathon Oil Corp. S-8 POS

2018-04-03 sec.gov
Document As filed with the Securities and Exchange Commission on April 3, 2018
Upvote Downvote

Related Articles

RDHL: Redhill Biopharma Ltd (OTC:REDIF) Analysis and Research Report

2018-04-18 - Asif

History and Development of the Company The company's legal and commercial name is RedHill Biopharma Ltd. The company's company was incorporated on August 3, 2009, and was registered as a private company limited by shares under the laws of the State of Israel. The company's principal executive offices are located at 21 Ha’arba’a Street, Tel Aviv, Israel. In February 2011, the company completed its initial public offering in Israel, pursuant to which the company issued 14,302,300 Ordinary Shares, and 7,151,150 tradable Series 1 Warrants to purchase 7,151,150 Ordinary Shares for aggregate gross proceeds of approximately $14 million. On December 27, 2012, the company completed the listing of its ADSs on the NASDAQ Capital Market. The company's Ordinary Shares are traded on the Tel-Aviv Stock Exchange under the symbol “RDHL,” and its ADSs are traded on the NASDAQ Capital Market under the same symbol "RDHL". The company's capital expenditures for the years ended December 31, 2...

SCYX: SCYNEXIS Analysis and Research Report

2018-04-16 - Asif

Overview SCYNEXIS, Inc. is a biotechnology company committed to positively impacting the lives of patients suffering from difficult-to-treat and often life-threatening infections by delivering innovative anti-infective therapies. SCYNEXIS is developing its lead product candidate, SCY-078, as the first representative of a novel oral and intravenous (IV) triterpenoid antifungal family in clinical development for the treatment of several serious fungal infections, including invasive candidiasis, invasive aspergillosis, refractory invasive fungal infections and vulvovaginal candidiasis (VVC). SCY-078 is a structurally distinct glucan synthase inhibitor that has been shown to be effective in vitro and in vivo against a broad range of human fungi pathogens such as Candida and Aspergillus species, including multidrug-resistant strains, as well as Pneumocystis species. Candida and Aspergillus species are the fungi responsible for approximately 85% of all invasive fungal infections in t...

ENRT: Enertopia Corp (CNSX:TOP) Analysis and Research Report

2018-04-16 - Asif

Business History Enertopia Corp. was formed on November 24, 2004 under the laws of the State of Nevada and commenced operations on November 24, 2004. From inception until April 2010, the company were primarily engaged in the acquisition and exploration of natural resource properties. Beginning in April 2010, the company began its entry into the renewable energy sector by purchasing an interest in a solar thermal design and installation company. In late summer 2013, the company began its entry into medicinal marijuana business. During its 2014 fiscal year end its activities in the clean energy sector were discontinued. During fiscal 2015 its activities in the Medicinal Marijuana sector were discontinued. During fiscal 2016 its activities in the Women’s personal healthcare sector were discontinued. The Company is actively pursuing business opportunities in the resource sector, whereby the company signed a definitive agreement for a Lithium Brine Project in May 2016. In May ...

FB: Facebook Analysis and Research Report

2018-04-15 - Asif

Overview The company's mission is to give people the power to build community and bring the world closer together. The company's top priority is to build useful and engaging products that enable people to connect and share with friends and family through mobile devices, personal computers, and other surfaces. The company also help people discover and learn about what is going on in the world around them, enable people to share their opinions, ideas, photos and videos, and other activities with audiences ranging from their closest friends to the public at large, and stay connected everywhere by accessing its products, including: Facebook enables people to connect, share, discover, and communicate with each other on mobile devices and personal computers. There are a number of different ways to engage with people on Facebook, the most important of which is News Feed which displays an algorithmically-ranked series of stories and advertisements individualized for each pers...

VSTM: Verastem Analysis and Research Report

2018-04-12 - Asif

Business Overview Verastem is a biopharmaceutical company focused on developing and commercializing drugs to improve the survival and quality of life of cancer patients. The company's most advanced product candidates, duvelisib and defactinib, utilize a multi-faceted approach to treat cancers originating either in the blood or major organ systems. Verastem is currently evaluating these compounds in both preclinical and clinical studies as potential therapies for certain cancers, including leukemia, lymphoma, lung cancer, ovarian cancer, mesothelioma, and pancreatic cancer. The company believe that these compounds may be beneficial as therapeutics either as single agents or when used in combination with immuno-oncology agents or other current and emerging standard of care treatments in aggressive cancers that are poorly served by currently available therapies. Duvelisib targets the Phosphoinositide 3-kinase (PI3K) signaling pathway. The PI3K signaling pathway plays a centr...

CUSIP: 565849106